Search SciPol

Brought to you by
What it does 

HR 6 would undertake a multitude of actions to address the opioid crisis in the United States by amending the following laws:

By amending those laws, HR 6 introduces several new provisions targeted at enhancing US systems of prevention, recovery, and treatment. Changes would be made to:

  • Medicaid coverage by ensuring: 
    • Medical assistance eligibility for juvenile inmates;
    • Streamlined, timely access to Medicaid coverage for former foster youth up to age 26;
    • Mental health and substance use services for targeted low-income children and pregnant women;
    • A qualified drug management program that will identify individuals who are at risk for abuse or misuse of controlled substances and designate them to healthcare providers and pharmacies for which the prescriptions of any controlled substance will be covered by the state;
    • Health home services to substance use disorder-eligible individuals; and
    • Coverage for medication-assisted treatment.
  • Medicare Coverage by ensuring:
    • Screening for opioid use disorder in all Medicare recipients;
    • Electronic transmission of prescription;
    • Drug management programs for at-risk beneficiaries; and
    • Coverage for opioid agonist and antagonist treatment medication, substance use counseling, individual or group therapy with a physician or a psychologist, toxicology testing, and other treatment-appropriate services.

In addition, HR 6 aims to:

  • Increase the number of qualified prescribers and healthcare providers and diversify their roles by:
    • Removing the limitations on time required to become nurse practitioners and physician assistants;
    • Increasing a pharmacist’s level of jurisdiction over declining to fill a prescription for controlled substances due to prescriptions that appear fraudulent, forged, or indicative of abuse or diversion;
    • Ensuring the right of hospice care facility workers to handle and dispose of any controlled substance that was lawfully dispensed to persons receiving hospice care;
    • Ensuring that substance use disorder treatment employees will receive a payment for any relative education that required the worker to seek out a loan;
    • Ensuring that no less than 50 Veteran Justice Outreach Specialists are hired to each be placed at a Veterans Affairs Medical Center; and
    • Ensuring an increase in support counselors for women.
  • Increase communication of viable information within and between healthcare providers and patients by ensuring:
    • The adoption of certified Electronic Health Record technology;
    • Educational resources on opioids and opioid alternatives;
    • Resources and information on proper prescribing methods;
    • Pain management guidelines for hospitals;
    • A public information dashboard from Health and Human Services that outlines best practices;
    • A nationwide toll-free phone number to poison control centers; and
    • A national public awareness campaign.

Finally, HR 6 would advance research and development by setting up two major initiatives. The Research Initiative aims to ensure high impact cutting-edge research that fosters scientific creativity and increases fundamental biological understanding on the prevention, diagnosis, and treatment of diseases and disorders. This initiative would include research required to respond to public health threats. And a second initiative aims to identify and develop technology for the detection of illicit fentanyl and other synthetic opioids entering the US by mail.

Status 

HR 6 was passed in the House of Representatives on June 22, 2018. It was introduced in the Senate on June 25, 2018.

Primary Author 
Bria Bugg, MS
Editor(s) 
Andrew Pericak, MEM
Recommended Citation 

Duke SciPol, "First Look: Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (HR 6, 115th Congress)" available at http://scipol.duke.edu/content/first-look-substance-use-disorder-prevention-promotes-opioid-recovery-and-treatment-support (07/30/2018).

License 
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Please distribute widely but give credit to Duke SciPol, linking back to this page if possible.